EMA backs first mRNA flu–COVID combination vaccine for older adults The EMA’s CHMP has issued a positive opinion for Moderna’s mRNA combination vaccine “mCombriax,” targeting both seasonal influenza and COVID‑19 in...
Overview The past week brought important signals on continental immunization strategies (Africa), local manufacturing (South Africa, India), next generation COVID-19 and mucosal vaccines (Europe, Asia–Pacific), and...
In 2025, the US government stopped recommending COVID-19 vaccines for healthy children, prompting insurers to drop coverage and leaving families with vulnerable members at risk. This abrupt change replaced the...